Rentokil Initial plc (NYSE:RTO) Stake Lessened by Tower Research Capital LLC TRC

Tower Research Capital LLC TRC lessened its stake in Rentokil Initial plc (NYSE:RTO - Free Report) by 73.8% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 4,569 shares of the company's stock after selling 12,892 shares during the quarter. Tower Research Capital LLC TRC's holdings in Rentokil Initial were worth $116,000 as of its most recent filing with the SEC.

Other institutional investors have also modified their holdings of the company. Cape Investment Advisory Inc. raised its stake in Rentokil Initial by 65.2% during the fourth quarter. Cape Investment Advisory Inc. now owns 1,505 shares of the company's stock worth $38,000 after acquiring an additional 594 shares during the period. CENTRAL TRUST Co raised its stake in Rentokil Initial by 15,208.3% during the fourth quarter. CENTRAL TRUST Co now owns 1,837 shares of the company's stock worth $47,000 after acquiring an additional 1,825 shares during the period. Smartleaf Asset Management LLC raised its stake in Rentokil Initial by 486.7% during the fourth quarter. Smartleaf Asset Management LLC now owns 1,942 shares of the company's stock worth $49,000 after acquiring an additional 1,611 shares during the period. Cromwell Holdings LLC acquired a new stake in Rentokil Initial during the fourth quarter worth about $59,000. Finally, Blue Trust Inc. grew its position in Rentokil Initial by 140.4% in the 4th quarter. Blue Trust Inc. now owns 2,402 shares of the company's stock worth $60,000 after purchasing an additional 1,403 shares during the last quarter. Institutional investors and hedge funds own 9.91% of the company's stock.

Rentokil Initial Stock Performance

NYSE RTO traded down $0.23 on Monday, hitting $23.04. The stock had a trading volume of 643,630 shares, compared to its average volume of 781,164. Rentokil Initial plc has a one year low of $19.60 and a one year high of $34.07. The company has a quick ratio of 0.96, a current ratio of 1.04 and a debt-to-equity ratio of 0.75. The stock has a market cap of $11.63 billion, a price-to-earnings ratio of 15.25, a P/E/G ratio of 7.95 and a beta of 0.96. The company's 50-day moving average is $22.47 and its two-hundred day moving average is $24.38.

Rentokil Initial Announces Dividend

The business also recently disclosed a semi-annual dividend, which will be paid on Thursday, May 15th. Stockholders of record on Friday, April 4th will be issued a $0.3825 dividend. This represents a dividend yield of 2.4%. The ex-dividend date of this dividend is Friday, April 4th. Rentokil Initial's dividend payout ratio (DPR) is presently 43.71%.

Wall Street Analyst Weigh In

Separately, Deutsche Bank Aktiengesellschaft restated a "buy" rating on shares of Rentokil Initial in a research report on Friday, March 7th. Three research analysts have rated the stock with a hold rating, one has issued a buy rating and two have issued a strong buy rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy".

Rentokil Initial Profile

Rentokil Initial plc, together with its subsidiaries, provides route-based services in North America, the United Kingdom, rest of Europe, Asia, the Pacific, and internationally. It offers a range of pest control services for rodents, and flying and crawling insects, as well as other forms of wildlife management for commercial customers.